Insights from 2023 ASH Annual Meeting
P

ASH 2023 Insights: "Acalabrutinib Added to Lenalidomide & Rituximab in Pts With Untreated Advanced Phase FL"

By Insights from 2023 ASH Annual Meeting FEATURING Paolo Strati
By Insights from 2023 ASH Annual Meeting FEATURING Paolo Strati
65 views
December 22, 2023
0 Comments
Login to view comments. Click here to Login

Featured Video

13:04
Winship Cancer Institute - Emory University

Treatment-Related Quality of Life in MF

Feat. A. Hunter

Featured Video

06:51
Insights from 2023 ASH Annual Meeting

ASH 2023 Insights: "Prevalence and Prediction of Ruxolitinib Tr…

Feat. D. Tremblay

Related Content

AUTOPLAY
13:56
SOHO 2023 Eleventh Annual Meeting

Follicular Lymphoma Management: What Is the New Order?

Feat. B. Kahl
27:51
Louisville Hematology Highlights

Summary of Recent Advances in Follicular Lymphoma

Feat. S. Gaballa
24:44
Indy Hematology Review

State of the Art in 2024: Emerging Therapies in Hematologic Malignan…

Feat. R. Birhiray
27:49
MyCancerHaven

Overview of the Diagnosis and Treatment of Follicular Lymphoma

Feat. R. Vij, T. Fehniger
15:08
SOHO 2022 Tenth Annual Meeting

SOHO 2022: Sequencing Therapy in Indolent Lymphoma - Treatment Choic…

Feat. L. Nastoupil
17:19
SOHO Turkey 2023

SOHO Turkey 2023: How I Treat Follicular Lymphoma

Feat. J. Lister
15:11
Penn Medicine Cellicon Valley '23: The Future of Cell and Gene Therapies

Lymphoma Bispecific Antibody Therapy and Management of CRS

Feat. D. Land, M. Hughes
11:12
SOHO 2023 Eleventh Annual Meeting

SOHO 2023 Next Questions: Indolent B-Cell Lymphoma

Feat. L. Nastoupil
36:10
University of Colorado Division of Hematology

2023 Denver ASH Review: Updates in CLL and Lymphoma

Feat. A. Major
14:36
Penn Medicine's 2024 Updates in Care of the Hematologic Malignancies Patient

The Latest Data on New Therapies in FL and MZL

Feat. J. Carter
38:55
Indy Hematology Review

Managing Indolent and Mantle Cell Lymphomas With Targeted and Cellul…

Feat. G. Salles
06:03
Yale Cancer Center

Yale School of Medicine Approach to Lymphadenopathy: Which Patients …

Feat. I. Isufi
17:41
5th SOHO Italy Annual Conference

SOHO Italy 2023: How I Manage Follicular, Marginal Zone and Mantle C…

Feat. S. Luminari
15:32
XIV Eurasian Hematology-Oncology Congress - EHOC 2023

Current Clinical Managment of Follicular Lymphoma

Feat. B. Ferhanoğlu
02:26
Insights from 2023 ASH Annual Meeting

ASH 2023 Insights: "Obinutuzumab, Lenalidomide, and Venetoclax …

Feat. C. Cheah
15:53
SOHO Brazil 2023

2023 SOHO® Brazil: "Treating First and Second Line Follicular L…

Feat. J. Alderuccio
22:14
MyCancerHaven

Experts Discuss Highlights in Lymphoma From ASCO® 2023

Feat. R. Vij, D. Russler-Germain
21:17
Yale Cancer Center

ASH 2022 Highlights: Follicular and Indolent NHL

Feat. F. Montanari
20:06
Yale Cancer Center

Managing Suspicious Lymphadenopathy After URI - Malignancy Considera…

Feat. P. Alam, F. Montanari
16:31
Penn Medicine's 2023 Updates in Care of the Hematologic Malignancies Patient

Advances in Follicular and Marginal Zone Lymphomas

Feat. J. Carter